USAMRIID Focuses on Genome Sequencing to Detect Variants

Home / Articles / External Government

U.S. Army Spc. Alexis Ouellette (R) vortexes reagents to create a homogenous mixture before passing them to U.S. Army Spc. Nolan Eubanks to add to samples at USAMRIID. The effort is part of the DoD SARS-CoV-2 Whole Genome Sequencing Action Plan, which brings together laboratories to conduct whole genome sequencing across the Military Health System in response to the COVID-19 pandemic (photo by Timothy R. Butcher, USAMRIID VIO).

January 10, 2023 | Originally published by US Army Medical Research Institute of Infectious Diseases on January 5, 2023

The U.S. Army Medical Research Institute of Infectious DiseasesOpens USAMRIID‘s Center for Genome Sciences played a key role in support during the COVID-19 pandemic.

The laboratory has consistently provided critical reagents, protocol development, and support for training in whole genome sequencing from the early phases of the pandemic to multiple stateside and overseas laboratories within the Armed Forces Health Surveillance Division Global Emerging Infections network.

Read Original Article